What Should Investors Know About AstraZeneca's Coronavirus Vaccine?

In this video from Motley Fool Live recorded on Nov. 23, Corinne Cardina, chief of Motley Fool's healthcare and cannabis bureau, and Brian Orelli, Fool.com contributor, discuss how AstraZeneca's (NASDAQ: AZN) coronavirus vaccine, AZD1222, works. They also talk about the recently released data showing that using a lower dose for the first vaccination seems to result in better protection than starting with the full dose. Finally, there's also a discussion about what investors should expect next from the company.

Continue reading

Source Fool.com